142 related articles for article (PubMed ID: 31241714)
1. FSH receptor binding inhibitor up-regulates ARID1A and PTEN genes associated with ovarian cancers in mice.
Gong Z; Shen X; Yang J; Yang K; Bai S; Wei S
Braz J Med Biol Res; 2019; 52(7):e8381. PubMed ID: 31241714
[TBL] [Abstract][Full Text] [Related]
2. FSH receptor binding inhibitor restrains follicular development and possibly attenuates carcinogenesis of ovarian cancer through down-regulating expression levels of FSHR and ERβ in normal ovarian tissues.
Zhuandi G; Tuanjie C; Luju L; Abdiryim A; Yingying D; Haoqin L; Suocheng W; Li D
Gene; 2018 Aug; 668():174-181. PubMed ID: 29783074
[TBL] [Abstract][Full Text] [Related]
3. Receptor Binding Inhibitor Suppresses Carcinogenesis of Cervical Cancer by Depressing Levels of FSHR and ERβ in Mice.
Gong Z; Shen X; Yang J; Lai L; Wei S
Anticancer Agents Med Chem; 2019; 19(14):1719-1727. PubMed ID: 31368878
[TBL] [Abstract][Full Text] [Related]
4. Determine the Role of FSH Receptor Binding Inhibitor in Regulating Ovarian Follicles Development and Expression of FSHR and ER
Lai L; Shen X; Liang H; Deng Y; Gong Z; Wei S
Biomed Res Int; 2018; 2018():5032875. PubMed ID: 30112396
[TBL] [Abstract][Full Text] [Related]
5. FSHR and LHR Expression and Signaling as Well as Maturation and Apoptosis of Cumulus-Oocyte Complexes Following Treatment with FSH Receptor Binding Inhibitor in Sheep.
Wei S; Shen X; Gong Z; Deng Y; Lai L; Liang H
Cell Physiol Biochem; 2017; 43(2):660-669. PubMed ID: 28942449
[TBL] [Abstract][Full Text] [Related]
6. FSH receptor binding inhibitor influences estrogen production, receptor expression and signal pathway during in vitro maturation of sheep COCs.
Zhuandi G; Haoqin L; Yingying D; Luju L; Suocheng W; Yingpai Z; You L
Theriogenology; 2017 Oct; 101():144-150. PubMed ID: 28708511
[TBL] [Abstract][Full Text] [Related]
7. Interaction of follicle-stimulating hormone (FSH) receptor binding inhibitor-8: a novel FSH-binding inhibitor, with FSH and its receptor.
Chitnis SS; Selvaakumar C; Jagtap DD; Barnwal RP; Chary KV; Mahale SD; Nandedkar TD
Chem Biol Drug Des; 2009 Jun; 73(6):637-43. PubMed ID: 19635055
[TBL] [Abstract][Full Text] [Related]
8. FSH receptor binding inhibitor impacts K-Ras and c-Myc of ovarian cancer and signal pathway.
Wei S; Shen X; Lai L; Liang H; Deng Y; Gong Z; Che T
Oncotarget; 2018 Apr; 9(32):22498-22508. PubMed ID: 29854294
[TBL] [Abstract][Full Text] [Related]
9. FSH receptor binding inhibitor depresses carcinogenesis of ovarian cancer via decreasing levels of K-Ras, c-Myc and FSHR.
Yang J; Gong Z; Shen X; Bai S; Bai X; Wei S
Anim Biotechnol; 2021 Feb; 32(1):84-91. PubMed ID: 31456468
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients.
Sluss PM; Schneyer AL
J Clin Endocrinol Metab; 1992 Jun; 74(6):1242-6. PubMed ID: 1592865
[TBL] [Abstract][Full Text] [Related]
11. Follicle-stimulating hormone induced epithelial-mesenchymal transition of epithelial ovarian cancer cells through follicle-stimulating hormone receptor PI3K/Akt-Snail signaling pathway.
Yang Y; Zhang J; Zhu Y; Zhang Z; Sun H; Feng Y
Int J Gynecol Cancer; 2014 Nov; 24(9):1564-74. PubMed ID: 25340291
[TBL] [Abstract][Full Text] [Related]
12. FSH and eCG impact follicles development and expression of ovarian FSHR and caspase-9 in mice.
Wei S; Gong Z; Guo H; Zhang T; Ma Z
Iran J Vet Res; 2017; 18(2):79-85. PubMed ID: 28775745
[TBL] [Abstract][Full Text] [Related]
13. Alarelin active immunization influences expression levels of GnRHR, FSHR and LHR proteins in the ovary and enhances follicular development in ewes.
Wei S; Chen S; Gong Z; Ouyang X; An L; Xie K; Dong J; Wei M
Anim Sci J; 2013 Jun; 84(6):466-75. PubMed ID: 23607296
[TBL] [Abstract][Full Text] [Related]
14. Expression of FSHR in chondrocytes and the effect of FSH on chondrocytes.
Kong D; Guan Q; Li G; Xin W; Qi X; Guo Y; Zhao J; Xu J; Sun S; Gao L
Biochem Biophys Res Commun; 2018 Jan; 495(1):587-593. PubMed ID: 29133260
[TBL] [Abstract][Full Text] [Related]
15. Alteration of follicle-stimulating hormone and testosterone regulation of messenger ribonucleic acid for Sertoli cell proteins in the rat during the acute phase of spinal cord injury.
Ottenweller JE; Li MT; Giglio W; Anesetti R; Pogach LM; Huang HF
Biol Reprod; 2000 Sep; 63(3):730-5. PubMed ID: 10952914
[TBL] [Abstract][Full Text] [Related]
16. Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice.
Wei S; Guo H; Gong Z; Zhang F; Ma Z
Immunopharmacol Immunotoxicol; 2016 Jun; 38(3):197-204. PubMed ID: 27075695
[TBL] [Abstract][Full Text] [Related]
17. Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.
Zhai Y; Kuick R; Tipton C; Wu R; Sessine M; Wang Z; Baker SJ; Fearon ER; Cho KR
J Pathol; 2016 Jan; 238(1):21-30. PubMed ID: 26279473
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of follicle-stimulating hormone (FSH)-receptor messenger RNA levels in the hamster ovary: effect of the endogenous and exogenous FSH.
Zhang YM; Roy SK
Biol Reprod; 2004 Jun; 70(6):1580-8. PubMed ID: 14749302
[TBL] [Abstract][Full Text] [Related]
19. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase C-mediated release of low molecular weight follicle-stimulating hormone receptor-binding inhibitor from testis membranes.
Sluss PM; Ewing JF; Schneyer AL
Biol Reprod; 1990 Dec; 43(6):1026-31. PubMed ID: 2127230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
